Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Credit agrmnt [a]
Director departure
Inv. presentation
Quarterly results
Acq. announced
|
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/26/2019 |
8-K
| Quarterly results |
| 05/21/2019 |
8-K
| Asset disposition |
| 05/14/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/07/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 05/06/2019 |
8-K
| Completion of Acquisition or Disposition of Assets |
| 04/19/2019 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/01/2019 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 02/27/2019 |
8-K
| Quarterly results |
| 02/19/2019 |
8-K
| Quarterly results |
| 11/21/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/31/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/22/2018 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 10/09/2018 |
8-K/A
| Quarterly results |
| 08/27/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/09/2018 |
8-K
| Quarterly results |
| 08/01/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Form of Articles Supplementary for 0% Series C Perpetual Convertible Preferred Stock",
"Form of Exchange Agreement, by and among Pernix Therapeutics Holdings, Inc., Deerfield Management L.P. and certain of its affiliates",
"The exchange of approximately $2.7 million aggregate principal amount of Senior Secured Notes by the Exchange Holders for 1,204,739 shares of Common Stock, which includes accrued and unpaid interest on the Senior Secured Notes; and",
"The exchange of approximately $2.7 million aggregate principal amount of Senior Secured Notes by the Exchange Holders for 1,204,739 shares of Common Stock, which includes accrued and unpaid interest on the Senior Secured Notes; and",
"Form of Amendment No. 3 to the ABL Facility, August 1, 2018, by and among Pernix, the guarantors and lenders party thereto and Cantor Fitzgerald Securities, as agent",
"Form of Amendment No. 2 to the Term Facility, by and among PIP DAC, the lenders party thereto and Cantor Fitzgerald Securities, as agent",
"Pernix Therapeutics Announces a Series of Transactions To Strengthen Its Balance Sheet and Improve Financial Flexibility MORRISTOWN, N.J. – August 1, 2018 – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, announces a series of transactions aimed at strengthening its balance sheet and improving financial flexibility, as described below. Exchange Agreement Pernix entered into exchange agreements with certain holders of Pernix’ s outstanding 12% Senior Secured Notes due 2020 for newly issued shares of common stock and shares of a newly created class of convertible preferred stock, the terms of which are described below . These transactions , are expected to close on August 1, 2018. The Exchange Transactions include:" |
|
| 07/31/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 06/22/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/22/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/10/2018 |
8-K
| Quarterly results |
| 04/23/2018 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 03/27/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/08/2018 |
8-K
| Quarterly results |
| 03/05/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits |
| 02/28/2018 |
8-K
| Other Events |
| 02/20/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/06/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/29/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/05/2018 |
8-K
| Cost Associated with Exit or Disposal Activities |
| 12/29/2017 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/05/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/15/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/07/2017 |
8-K
| Quarterly results |
| 10/17/2017 |
8-K
| Quarterly results |
|
|
|